Literature DB >> 21477394

Breast pain.

Amit Goyal1.   

Abstract

INTRODUCTION: Breast pain may be cyclical (worse before a period) or non-cyclical, originating from the breast or the chest wall, and occurs at some time in 70% of women. Cyclical breast pain resolves spontaneously in 20% to 30% of women, but tends to recur in 60% of women. Non-cyclical pain responds poorly to treatment but tends to resolve spontaneously in half of women. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for breast pain? We searched: Medline, Embase, The Cochrane Library, and other important databases up to May 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 24 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antibiotics, bromocriptine, combined oral contraceptive pill, danazol, diuretics, evening primrose oil, gestrinone, gonadorelin analogues, hormone replacement therapy (HRT), lisuride, low-fat diet, progestogens, pyridoxine, tamoxifen, tibolone, topical or oral non-steroidal anti-inflammatory drugs (NSAIDs), toremifene, and vitamin E.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477394      PMCID: PMC3275318     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  33 in total

1.  A double-blind randomized controlled trial of toremifen therapy for mastalgia.

Authors:  Chang Gong; Erwei Song; Weijuan Jia; Li Qin; Jujiang Guo; Haixia Jia; Xiaoqu Hu; Fengxi Su
Journal:  Arch Surg       Date:  2006-01

2.  Treatment of mastalgia with bromocriptine: a double-blind cross-over study.

Authors:  M Blichert-Toft; A N Anderson; O B Henriksen; T Mygind
Journal:  Br Med J       Date:  1979-01-27

3.  Mastalgia and total body water.

Authors:  P E Preece; A R Richards; G M Owen; L E Hughes
Journal:  Br Med J       Date:  1975-11-29

4.  Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial.

Authors:  Jacqueline Blommers; Elisabeth S m de Lange-De Klerk; Dirk J Kuik; Pieter D Bezemer; Sybren Meijer
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

5.  Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss.

Authors:  C Roux; C Pelissier; J Fechtenbaum; S Loiseau-Peres; C L Benhamou
Journal:  Osteoporos Int       Date:  2002-03       Impact factor: 4.507

6.  Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study.

Authors:  S Oksa; T Luukkaala; J Mäenpää
Journal:  BJOG       Date:  2006-06       Impact factor: 6.531

7.  Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study.

Authors:  S Kaleli; Y Aydin; C T Erel; U Colgar
Journal:  Fertil Steril       Date:  2001-04       Impact factor: 7.329

Review 8.  Overview of the main outcomes in breast-cancer prevention trials.

Authors:  J Cuzick; T Powles; U Veronesi; J Forbes; R Edwards; S Ashley; P Boyle
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

9.  Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment.

Authors:  Tahsin Colak; Turgut Ipek; Arzu Kanik; Zekai Ogetman; Suha Aydin
Journal:  J Am Coll Surg       Date:  2003-04       Impact factor: 6.113

10.  Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy.

Authors:  Stefano Palomba; Costantino Di Carlo; Michele Morelli; Tiziana Russo; Roberto Noia; Carmine Nappi; Pasquale Mastrantonio; Fulvio Zullo
Journal:  Maturitas       Date:  2003-08-20       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.